Re: [113attendees] IETF 113 Update: 2022-02-10
"Scheffenegger, Richard" <rs.ietf@gmx.at> Fri, 18 February 2022 18:35 UTC
Return-Path: <rs.ietf@gmx.at>
X-Original-To: 113attendees@ietfa.amsl.com
Delivered-To: 113attendees@ietfa.amsl.com
Received: from localhost (localhost [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id B66763A12E8 for <113attendees@ietfa.amsl.com>; Fri, 18 Feb 2022 10:35:15 -0800 (PST)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: -2.613
X-Spam-Level:
X-Spam-Status: No, score=-2.613 tagged_above=-999 required=5 tests=[BAYES_00=-1.9, DKIM_SIGNED=0.1, DKIM_VALID=-0.1, FREEMAIL_FROM=0.001, NICE_REPLY_A=-0.714, RCVD_IN_MSPIKE_H2=-0.001, SPF_HELO_NONE=0.001, SPF_PASS=-0.001, URIBL_BLOCKED=0.001] autolearn=ham autolearn_force=no
Authentication-Results: ietfa.amsl.com (amavisd-new); dkim=pass (1024-bit key) header.d=gmx.net
Received: from mail.ietf.org ([4.31.198.44]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id CR1e656PWbG4 for <113attendees@ietfa.amsl.com>; Fri, 18 Feb 2022 10:35:08 -0800 (PST)
Received: from mout.gmx.net (mout.gmx.net [212.227.15.18]) (using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits)) (No client certificate requested) by ietfa.amsl.com (Postfix) with ESMTPS id CB9AD3A12D8 for <113attendees@ietf.org>; Fri, 18 Feb 2022 10:35:07 -0800 (PST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/simple; d=gmx.net; s=badeba3b8450; t=1645209305; bh=p0wPO1JNxlD034S5nAWB8NCYwOEr97c+0UEj/iK6rUA=; h=X-UI-Sender-Class:Date:Subject:To:References:From:In-Reply-To; b=cCPS56Hkb03xrfaJHgPe+QaeAtc91gsdb3f+8aMD5TayT974AIk5gR9x/eWZtYAFG fG6mfWI5tSrj4bm6D1gyZtDsHrjYeBtnJ0a/ThxAYb++QizgTHUSae+EQyjmuoky8X 4+Jn/fu60AS0RDcaGbG2xna7a7pKNSpp4pKP9/mM=
X-UI-Sender-Class: 01bb95c1-4bf8-414a-932a-4f6e2808ef9c
Received: from [192.168.233.112] ([185.236.167.136]) by mail.gmx.net (mrgmx005 [212.227.17.190]) with ESMTPSA (Nemesis) id 1Mg6e4-1nul5b2viY-00heAF for <113attendees@ietf.org>; Fri, 18 Feb 2022 19:35:05 +0100
Message-ID: <891fdb32-ce7f-083e-d494-2ecf0dbf7330@gmx.at>
Date: Fri, 18 Feb 2022 19:35:05 +0100
MIME-Version: 1.0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:91.0) Gecko/20100101 Thunderbird/91.5.1
To: 113attendees@ietf.org
References: <41FACD64-7B36-4842-AF45-308AD35276D6@tzi.org> <90572B0D-F4A8-4D10-A27E-80C545568E4E@ietf.org> <4bc7c820-b671-14c5-32b4-e1001b66aa76@na-nic.com.na> <6636b979-c2ef-b31a-497f-f5a68c3490ee@gmail.com>
From: "Scheffenegger, Richard" <rs.ietf@gmx.at>
In-Reply-To: <6636b979-c2ef-b31a-497f-f5a68c3490ee@gmail.com>
Content-Type: text/plain; charset="UTF-8"; format="flowed"
Content-Transfer-Encoding: quoted-printable
X-Provags-ID: V03:K1:0Jj13/wefUvVFnH3YpJGDgpSQpnbpfh0CZwWD6HnwQJm7G3zBXs fvtkykTPazPXK8EodJqHS7qNnEKJ7ptbutpVq7I2LBNvCvba4ToieZnS2AY9ksA+qaDOacR faYH97BdI4aJuEspEwS6cIfPAAPAsX/PsAl4HvFt/3JJ4VVmLA1jzF16GYccEXd+7XnX/VS xafaR9K/if/mlww4qr66w==
X-UI-Out-Filterresults: notjunk:1;V03:K0:U/ijXIMwH+Q=:rU9zBKu2tzrmrrUlKrHYJl VYRdsBPlfwghLnMnYse0CgATbun9VoRbe3l47O5ct35B34Lt54UsnZnZATrSsJJ0WTrDv61j1 yQaerkY/V70DpQbXo0BWj/vMlW3hKGfbRu6gdOcHYxOvF4hLkPb12urZpvRtee8+3h4q+mLfG dGFRyeM+ss9AOFJKGZhIEC193Py+GYSMjcmRFSP8rCIDMyIwTprzR9J8u9BK1Eum8uKB2/lkl DFwKH2FQcJLUY+pecMGO2VxdF3AeAKYad2KUx7LKKpHdarRGu+YpWWjPaQaX6X6A+ZLDx+T6H //loC+YeDca9IaYjniwpKb3wEA9n+5IR68SzM6KWxCR2p+ptPW1yi5twosIGoN605V1lbwUwo nnm+XdQikZlnKCI2nY3LsNUV/ehXXjnER5uBVHwXHI2aW9uMGRSXhV5uTRxPg/FyILpA8rXLI oYj+KAUMFnzG+SNHtF2yAdKBnbEnwb8UCbmsnHxc1kM36lwFgKNcBJXyPbWGnF8AGuv85Aunt DK/J45ylikkeqxCztxBKCelypUyJf7sR79KW+JwxJTQOH720n2ErGS6H3FswpgVKj00eMpkyT MPY+QBtoraWAJ3bINzQirbcDEsqOoP1Rd2mx+x1atoD4xspoVLrobv+lBeSeHu1c/4cLGRBra xpGZL4XLc2oAPy/W/+/JKFlObpeupQRakkxuaSQKBjs6pkIxdp7kGOY1kcgueh8aMFhNw4Lse xRHkhg5gZF6PIrrOGCyIJgM1LQ3UZyYh/RzTFfMjPTsbqGDMTvTK94JNTVCBmTjZN+9qlMfPf wYWWwNCZbtjn7Rk0Ds5bFT2fMo8/y+lVTOgE/G7y9mas6l5enUgeWRaLzqoi8psaGsgVvE+gb QEdIQEcesMMyHgV3DeaVk6OA6XHnybl6ftf6CIANkT5VhVoc6P28ude1gHODl2EY5c60S9aAB Y7pjDIeUgJUe/7iuNbho3AUSc4AikaDphbf5oujBE0QiIi5kqMBSIEc4jydmsBewKZKwO44Za 95SfpLp9+Qi3D33HaLlILnBfpiVK00uZngunKvWJwiVWT0jRdWQ3dBV85G2Dcr1pxSqNZnMoE +ZggVymsS9eBwY=
Archived-At: <https://mailarchive.ietf.org/arch/msg/113attendees/7_86uMTH-lbWNY1OFxeU3X6wWgU>
Subject: Re: [113attendees] IETF 113 Update: 2022-02-10
X-BeenThere: 113attendees@ietf.org
X-Mailman-Version: 2.1.29
Precedence: list
List-Id: Mailing list for IETF 113 attendees <113attendees.ietf.org>
List-Unsubscribe: <https://www.ietf.org/mailman/options/113attendees>, <mailto:113attendees-request@ietf.org?subject=unsubscribe>
List-Archive: <https://mailarchive.ietf.org/arch/browse/113attendees/>
List-Post: <mailto:113attendees@ietf.org>
List-Help: <mailto:113attendees-request@ietf.org?subject=help>
List-Subscribe: <https://www.ietf.org/mailman/listinfo/113attendees>, <mailto:113attendees-request@ietf.org?subject=subscribe>
X-List-Received-Date: Fri, 18 Feb 2022 18:35:23 -0000
It is important to note, that the public health measures are not designed to cater for a specific individual. Just to make the burden on the healthcare system low enough, that it does not collapse entirely. This is also one of the reasons, why in the past a vaccination with even as low an effectivity as 40% was deemed dramatically better, than not vaccinating at all (vaccination against CoVID is typically at the very high end of effectiveness when it comes to vaccines and "wetware"). It appears, that many (westerly) countries have now achieved a state, where the risk or a systemic overload of the public healthcare system is no longer a dramatic threat - at least during the warmer months in the northern hemisphere, and pending any new (more aggressive / more deadly) variant. I am personally more worried about those regions, where widespread vaccination was not yet possible, or where draconic measures keep the exposure level (thus the build-up of natural immunity) low. But more for the reason that I personally, as a boostered individual may be a carrier (vector) of the virus without knowing/symptoms, and transmitting it in these regions causing detrimental health to so far unexposed persons. (Compare transmissible deceases after explorers from - traditionally - europe came to visit other parts of the globe) Having that said, at least in western europe / northern america, it becomes a matter of personal choice - just like with nearly all other viridae which are endemic in the human population, and cause more or less severe symptoms of a cold or flu - if one wants to get vaccinated or not. Those who choose not to get vacciated via well-tested, fully understood immuno-response medication will contract the virus in circulation. With all the benefits (no time spent waiting in line for the shot, no needle, no violation of the personal sphere of the skin) and drawbacks (dramatically higher risk of "side-"effects like loss of taste and smell, fatigue syndrome, heart inflammation, long-term neurological issues if initial indications of Covid hiding in the central nervous system like Herpes turn out to be correct in 5-25 years). There are in the order of 20 different types of viridae in endemic circulation, which all typically cause only mild flu-like symptoms, but every once in a while, turn out to be deadly for an individuum. The only other choice would be the voluntary non-participation in all direct human contact - "social" distancing for the entire rest of that individuals life. Which, by the way, would not only protect with extreme high success rate against Covid, but virtually all other transmissible deseases. (But not exposing the immune system to any pathogens regularly will probably have its own risks) In that light - take care! Richard Am 18.02.2022 um 17:08 schrieb Alexandre Petrescu: > But I wonder what about vaccinating? > > It might be that not only PCR and distancing to be no longer required at > Vienna by end of March, but the vaccination neither. > > The EMA press conf of yesterday (17 february) still does not say > something affirmative about 4th dose for the general public. > > But it says (https://youtu.be/W9HPf0PJda0?t=144) that EMA considers, not > decided yet, reducing the time from 2nd dose to 3rd dose to 3 month. > > If the time from 2nd dose to 3rd dose is 3 month, then I the non-medical > person, suppose the same 3 month would be between 3rd dose and 4th dose > too. Is this supposition appropriate? > > My 3rd dose was in December 2021, so the 4th would need to be in March, > prior to Vienna. > > In that EMA press conference (https://youtu.be/W9HPf0PJda0?t=211) it is > said: > - 2nd booster? not enough information, need more info to understand > effect of current vaccination, the impact of 4th dose where it was applied. > - EMA talks about a 'preprint' with Israel results that could be a > starting point to analyse. I dont know which paper. > > But I heard of another recent medrxiv paper which seems to be saying 4th > dose is good > (https://www.medrxiv.org/content/10.1101/2022.02.15.22270948v1). There > is also a video from Israel as early as January, which says 4th dose is > good - https://youtu.be/71viRng-k8g > But today it is also told that Israel removes 'pass' requirements, so no > more vaccination requirement in Israel, presumably. > > I dont know what to think about vaccination.
- [113attendees] IETF 113 Update: 2022-02-10 Greg Wood
- Re: [113attendees] IETF 113 Update: 2022-02-10 Michael Richardson
- Re: [113attendees] IETF 113 Update: 2022-02-10 Dr Eberhard W Lisse
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jeffrey (Zhaohui) Zhang
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Vittorio Bertola
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexander Mayrhofer
- [113attendees] Breaking news: IETF 113 will be af… Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Bob Hinden
- Re: [113attendees] IETF 113 Update: 2022-02-10 Toerless Eckert
- Re: [113attendees] IETF 113 Update: 2022-02-10 Andrew Campling
- Re: [113attendees] IETF 113 Update: 2022-02-10 Joel M. Halpern
- Re: [113attendees] IETF 113 Update: 2022-02-10 Eric Vyncke (evyncke)
- Re: [113attendees] IETF 113 Update: 2022-02-10 Warren Kumari
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexander Mayrhofer
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jan Zorz - Go6
- [113attendees] Predicting go/no go dates for IETF… Jim Reid
- Re: [113attendees] Predicting go/no go dates for … Salz, Rich
- Re: [113attendees] Predicting go/no go dates for … Jan Zorz - Go6
- Re: [113attendees] Predicting go/no go dates for … Jim Reid
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jay Daley
- Re: [113attendees] IETF 113 Update: 2022-02-10 Carsten Bormann
- Re: [113attendees] IETF 113 Update: 2022-02-10 Marc Petit-Huguenin
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jay Daley
- Re: [113attendees] IETF 113 Update: 2022-02-10 Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Dr Eberhard W Lisse
- Re: [113attendees] IETF 113 Update: 2022-02-10 Vittorio Bertola
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 John C Klensin
- Re: [113attendees] IETF 113 Update: 2022-02-10 Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Michael Richardson
- Re: [113attendees] IETF 113 Update: 2022-02-10 Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jan Zorz - Go6
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Eberhard W Lisse
- Re: [113attendees] IETF 113 Update: 2022-02-10 Scheffenegger, Richard
- Re: [113attendees] IETF 113 Update: 2022-02-10 Jan Zorz - Go6
- Re: [113attendees] IETF 113 Update: 2022-02-10 Petr Špaček
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Petr Špaček
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre PETRESCU
- Re: [113attendees] Breaking news: IETF 113 will b… Alexandre Petrescu
- Re: [113attendees] Breaking news: IETF 113 will b… Alexander Mayrhofer
- Re: [113attendees] Breaking news: IETF 113 will b… Marc Petit-Huguenin
- Re: [113attendees] Breaking news: IETF 113 will b… Greg Wood
- Re: [113attendees] Breaking news: IETF 113 will b… Rohan Mahy
- Re: [113attendees] Breaking news: IETF 113 will b… Marc Petit-Huguenin
- Re: [113attendees] Breaking news: IETF 113 will b… Eric Vyncke (evyncke)
- Re: [113attendees] Breaking news: IETF 113 will b… Dr Eberhard W Lisse
- Re: [113attendees] Breaking news: IETF 113 will b… Corine de Kater
- Re: [113attendees] Breaking news: IETF 113 will b… Marc Petit-Huguenin
- Re: [113attendees] Breaking news: IETF 113 will b… Scheffenegger, Richard
- Re: [113attendees] Breaking news: IETF 113 will b… Alexandre Petrescu
- Re: [113attendees] Breaking news: IETF 113 will b… Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu
- Re: [113attendees] IETF 113 Update: 2022-02-10 Alexandre Petrescu